Cerus Corporation
Clinical trials sponsored by Cerus Corporation, explained in plain language.
Develops blood safety products, including pathogen reduction systems for blood components.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New blood treatment could make transfusions safer for heart surgery
Disease control CompletedThis study tested a special way to treat donated red blood cells to kill germs, called the INTERCEPT Blood System. It involved 581 people having complex heart surgery who needed blood transfusions. The goal was to see if this treated blood is as safe and works as well as regular …
Phase: PHASE3 • Sponsor: Cerus Corporation • Aim: Disease control
Last updated Jun 26, 2026 16:32 UTC
-
Can treated platelets last 5 days? new study finds out
Knowledge-focused CompletedThis study looked at whether platelets treated with the INTERCEPT system and stored for 5 days work as well as fresh platelets. 40 healthy adults donated platelets, which were treated and stored, then compared to fresh platelets. The goal was to see how many platelets survived af…
Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC